ANTIBIOTIC-INDUCED CARDIAC ARRHYTHMIA IN ELDERLY PATIENTS (original) (raw)
Relation of Clinical, Echocardiographic and Electrocardiographic Features of Cardiac Amyloidosis to the Presence of the Transthyretin V122I Allele in Older African-American Men
James Koziol
The American Journal of Cardiology, 2011
View PDFchevron_right
Transthyretin cardiac amyloidosis: an under-diagnosed cause of heart failure
Marc Mugmon
Journal of Community Hospital Internal Medicine Perspectives, 2014
View PDFchevron_right
Cardiac amyloidosis in African Americans: Comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis
Rodney Falk
American Heart Journal, 2009
View PDFchevron_right
Wild-type TTR amyloidosis among patients with unexplained heart failure and systolic LV dysfunction
Shay Livschitz
PLOS ONE, 2021
View PDFchevron_right
Cardiac amyloidosis: a changing epidemiology with open challenges
Vessel Plus
Vessel Plus, 2022
View PDFchevron_right
Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis
Ivailo Tournev
JACC: Heart Failure, 2021
View PDFchevron_right
Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction
Carolina Robles
European Heart Journal, 2015
View PDFchevron_right
Transthyretin-related amyloidoses and the heart: a clinical overview
Candida Cristina Quarta
Nature Reviews Cardiology, 2010
View PDFchevron_right
Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure
sabrina frusconi
European journal of heart failure, 2018
View PDFchevron_right
Cardiac amyloidosis. Two main subtypes and diagnosis by Nuclear Medicine: SPET tracer revival 1 2
Pipitsa N Valsamaki
Hell J Nucl Med, 2019
View PDFchevron_right
Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies
James Koziol
American Heart Journal, 2010
View PDFchevron_right
Cardiac amyloidosis: An underdiagnosed/underappreciated disease
Antonis Manolis
European Journal of Internal Medicine, 2019
View PDFchevron_right
Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis
Anique Ducharme
Canadian Journal of Cardiology, 2020
View PDFchevron_right
Re-Definition of the Epidemiology of Cardiac Amyloidosis
Riccardo Saro
Biomedicines
View PDFchevron_right
P2787Incidence of transthyretin cardiac amyloidosis in patients with non-ischemic cardiomyopathy
Shay Livschitz
European Heart Journal, 2018
View PDFchevron_right
Pondering the Prognosis and Pathology of Cardiac Amyloidosis
Rodney Falk
Jacc-cardiovascular Imaging, 2016
View PDFchevron_right
Racial and Ethnic Disparities in Transthyretin Cardiac Amyloidosis
Gabriela Bonilla
Current Cardiovascular Risk Reports, 2021
View PDFchevron_right
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective
Giampaolo Merlini
European Heart Journal, 2013
View PDFchevron_right
Identification of prognostic markers in transthyretin and AL cardiac amyloidosis*
Dania Mohty
Amyloid, 2016
View PDFchevron_right
The electrocardiographic features associated with cardiac amyloidosis of variant transthyretin isoleucine 122 type in Afro-Caribbean patients
Julian Gillmore
American Heart Journal, 2012
View PDFchevron_right
The Amyloidogenic V122I Transthyretin Variant in Elderly Black Americans
Rodney Falk
New England Journal of Medicine, 2015
View PDFchevron_right
Amyloid Heart Disease
Rodney Falk
Progress in Cardiovascular Diseases, 2010
View PDFchevron_right
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis
Marc Silver
Journal of the American College of Cardiology, 2016
View PDFchevron_right
P2786Tc99m PYP scintigraphy to diagnose transthyretin cardiac amyloidosis in patients with heart failure
Shay Livschitz
European Heart Journal, 2018
View PDFchevron_right
Transthyretin Cardiac Amyloidosis in Black Americans
Olakunle Akinboboye
Circulation. Heart failure, 2016
View PDFchevron_right
Amyloid diseases of the heart: assessment, diagnosis, and referral
Simon Dubrey
Heart, 2011
View PDFchevron_right
Cardiac Amyloid for the Internist
Hassan Ashraf
Cureus, 2021
View PDFchevron_right
Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis
Candida Cristina Quarta
Circulation
View PDFchevron_right
Homozygosity for the V122I mutation in transthyretin is associated with earlier onset of cardiac amyloidosis in the african american population in the seventh decade of life
Jason Theis
2014
View PDFchevron_right
Frequency and distribution of senile cardiovascular amyloid
Wendy Murdoch
The American Journal of Medicine, 1983
View PDFchevron_right
Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry
Aparna Saha
JAMA
View PDFchevron_right